ADC Therapeutics

Develops proprietary antibody drugs targeting cancer

Launch date

2011

Employees

Ownership

private equity, public, venture capital

Market cap

Net debt

-

Firm valuation

$1.7b (Public information from Apr 2021)

Lausanne Canton of Vaud (HQ)

http://www.adctherapeutics.com/

https://twitter.com/adctherapeutics https://www.linkedin.com/company/adc-therapeutics/

Innovation Topic

Parent Project

Market Maturity

Key innovator locations

Project Participants

Project participant locations